These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28496968)

  • 1. Resolving shortages of prescription drugs: the case for public-private collaboration.
    Katz EE
    Isr J Health Policy Res; 2017; 6():28. PubMed ID: 28496968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug shortages in Israel: regulatory perspectives, challenges and solutions.
    Schwartzberg E; Ainbinder D; Vishkauzan A; Gamzu R
    Isr J Health Policy Res; 2017; 6():17. PubMed ID: 28392910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABPI responds to article on concept of Pharmacare.
    Whitehead S
    BMJ; 2012 Jan; 344():e736. PubMed ID: 22293381
    [No Abstract]   [Full Text] [Related]  

  • 4. Forget sponsorship and free trips--welcome to Pharmacare.
    Moynihan R
    BMJ; 2011 Jan; 344():d8316. PubMed ID: 22218100
    [No Abstract]   [Full Text] [Related]  

  • 5. Surmounting shortages. GPOs work creatively with manufacturers to avert drug shortfalls.
    Rubenfire A
    Mod Healthc; 2015 Oct; 45(43):16-8. PubMed ID: 26619618
    [No Abstract]   [Full Text] [Related]  

  • 6. The new regulatory tools of the 2016 Health Law to fight drug shortages in France.
    Bocquet F; Degrassat-Théas A; Peigné J; Paubel P
    Health Policy; 2017 May; 121(5):471-476. PubMed ID: 28366432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public-private collaborations and partnerships in stratified medicine: making sense of new interactions.
    Chataway J; Fry C; Marjanovic S; Yaqub O
    N Biotechnol; 2012 Sep; 29(6):732-40. PubMed ID: 22446473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public-Private Partnerships in Lead Discovery: Overview and Case Studies.
    Gottwald M; Becker A; Bahr I; Mueller-Fahrnow A
    Arch Pharm (Weinheim); 2016 Sep; 349(9):692-7. PubMed ID: 27335205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combating drug shortages in China: surveillance warning and practice standardization.
    Shi Y; Yang P; Li X; Lv J; Yin T; Gong Z; Sun S; Zhou B
    Int J Clin Pharm; 2020 Apr; 42(2):309-314. PubMed ID: 32048122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Despite Federal Legislation, Shortages Of Drugs Used In Acute Care Settings Remain Persistent And Prolonged.
    Chen SI; Fox ER; Hall MK; Ross JS; Bucholz EM; Krumholz HM; Venkatesh AK
    Health Aff (Millwood); 2016 May; 35(5):798-804. PubMed ID: 27140985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug shortages: Implications for medical toxicology.
    Mazer-Amirshahi M; Hawley KL; Zocchi M; Fox E; Pines JM; Nelson LS
    Clin Toxicol (Phila); 2015 Jul; 53(6):519-24. PubMed ID: 25951876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription Drug Shortages: Implications for Ambulatory Pediatrics.
    Donnelly KA; Zocchi MS; Katy TA; Fox ER; van den Anker JN; Mazer-Amirshahi ME
    J Pediatr; 2018 Aug; 199():65-70. PubMed ID: 29752177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with drug shortages in Canada: a retrospective cohort study.
    Zhang W; Guh DP; Sun H; Lynd LD; Hollis A; Grootendorst P; Anis AH
    CMAJ Open; 2020; 8(3):E535-E544. PubMed ID: 32873582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Academic, Foundation, and Industry Collaboration in Finding New Therapies.
    Ramsey BW; Nepom GT; Lonial S
    N Engl J Med; 2017 May; 376(18):1762-1769. PubMed ID: 28467868
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarker qualification via public-private partnerships.
    Eck SL; Paul SM
    Clin Pharmacol Ther; 2010 Jan; 87(1):21-3. PubMed ID: 20019697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACMT Position Statement on Prescription Drug Shortages.
    Mazer-Amirshahi M; Fox ER; Nelson LS; Smith SW; Stolbach AI
    J Med Toxicol; 2020 Jul; 16(3):349-351. PubMed ID: 32297150
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug shortages--Congress listens, FDA acts.
    Thompson CA
    Am J Health Syst Pharm; 2012 Jan; 69(2):90-1. PubMed ID: 22215347
    [No Abstract]   [Full Text] [Related]  

  • 18. Inter-organizational relationships of health partnerships: characteristics of the Fulton County SPARC Program.
    Sullivan BA
    J Health Hum Serv Adm; 2012; 35(1):44-70. PubMed ID: 22838056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 20. Public Health and Hospitals: Lessons Learned From Partnerships in a Changing Health Care Environment.
    Scutchfield FD; Prybil L; Kelly AV; Mays GP
    Am J Public Health; 2016 Jan; 106(1):45-8. PubMed ID: 26562110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.